Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy

doi:10.3748/wjg.v23.i11.2060

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9917)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

575

WORD

329

HTML

5103

Figures (1-3)

234

Tables (1-3)

273

Sum=6514

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1235

Download

2168

Sum=3403

Mar 21, 2017 (publication date) through Jan 5, 2025

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Mar 21, 2017; 23(11): 2060-2067
Published online Mar 21, 2017. doi: 10.3748/wjg.v23.i11.2060

Full Size Figure Download Figure

Figure 3 Correlation between the cytochrome P450 2C19 genotype and the total frequency scale for symptoms of gastroesophageal reflux disease score in the erosive esophagitis and non-erosive reflux disease patients. FSSG: Frequency scale for symptoms of gastroesophageal reflux disease; EE: Erosive esophagitis; NERD: Non-erosive reflux disease; RM: Rapid metabolizer; IM: Intermediate metabolizer; PM: Poor metabolizer.

Citation: Kawara F, Fujita T, Morita Y, Uda A, Masuda A, Saito M, Ooi M, Ishida T, Kondo Y, Yoshida S, Okuno T, Yano Y, Yoshida M, Kutsumi H, Hayakumo T, Yamashita K, Hirano T, Hirai M, Azuma T. Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy. World J Gastroenterol 2017; 23(11): 2060-2067
URL: https://www.wjgnet.com/1007-9327/full/v23/i11/2060.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i11.2060